We have previously demonstrated that, while most enzymatic formation of 5-methycytosine in the DNA of mammalian cells occurs very shortly after strand synthesis, there is also a minor fraction of methyiation which occurs in some DNA sequences up to at least several hours after strand synthesis.
INTRODUCTION
Most interest in 5-methyl cytosine 1n the DNA of mammalian cells is concentrated on its possible involvement in the control of gene activity (1, 2) .
Inhibitors of 5-methylcytosine formation (especially 5-azacytidine) have been important tools for the experimental alteration of methyiation patterns and have strongly Implicated DNA methyiation in mammalian gene control (3, 4, 5, 6) . Also the mapping of methylated sites in the DNA of mammalian cells using restriction enzymes sensitive to the methyiation status of specific sequences in various cellular genes have shown that undermethylation at some sites in various genes seems to be associated with, but is not a sufficient condition for, activation of those genes (7, 8, 9, 10) .
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Nucleic Acids Research (even at the Okazaki fragment stage (11)), we have shown that the methylation at some sites In the DNA of 4 different types of cultured mammalian cells (of human, hamster, and mouse origin) is delayed for up to several hours after strand synthesis (12) . The methylation at these sites is completed before these strands act as templates in the next S-phase (12) . The existence of a class of DMA sequences showing these kinetics of enzymatic methylation was predicted by J.H. Taylor (13) who suggested that such sequences might be specific sites for the initiation of DNA replication in mammalian cells.
As part of our experimental programme to try to establish what significance, 1f any, those DNA sequences 1n which methylation is delayed have for the functioning of mammalian cells, we have examined the effects of several different compounds which have been reported to inhibit, or which might possibly inhibit, methylation reactions. The questions we addressed in this study were:
(a) whether these compounds do in fact inhibit DMA methylation; (b) whether any of these compounds show a differential effect on the Inhibition of delayed and non-delayed DNA methylation reactions (and hence their differential Inhibitory properties might be useful in determining the importances of these different classes of DNA methylation in cellular functioning); and (c) to try to determine whether different maintenance methylases perform these two different classes of DNA methylation reactions.
MATERIALS AND METHODS
These experiments used a cell line ("Crow" cells) derived from a human brain tumour in the laboratory of Dr. T.R. Bradley, Biological Research Unit, Cancer Institute, Melbourne.
Crow cells were grown as a monodisperse suspension culture in Eagle's Minimum Essential Medium (MEM) with 101 foetal calf serum (both from Flow Laboratories, Stanmore, N.S.W.). The cells were subcultured twice weekly (usually 1/10 each time) and were monitored for mycoplasma contamination by a dual label incorporation technique (14) .
All of the potential inhibitors of methylation tested 1n these experiments were purchased from the Sigma Chemical Co., St. Louis, M.O., USA. TubeMcidin and also HTA were dissolved at lOmM 1n the medium used for labelling with [me-H]methionine. Homocysteine thiolactone was dissolved at lOOmM in 1M Hepes buffer pH 7.4. The other drugs were dissolved in distilled water. All were sterilized using a 0.2fjm filter immediately before use. The labelling medium consisted of MEM without glutamine or methionine (Flow Laboratories) supplemented with 101 foetal calf serum, 3mM glutamine, 20mM sodium formate, 20U/ml Gentamicin, 20mM Hepes buffer, 10 uM bromodeoxyuridine (BrdUrd) Incubated 1n labelling medium with drug for 6 hours before being collected and the DNA extracted and purified as described previously (15) . The purified DNA was banded in alkaline CsCl/Cs 2 S0 4 gradients as previously described (12) .
The absorbance at 260 nm together with 3 H and * C content were determined by methods described 1n reference 15. strands synthesized during the BrdUrd-labelling period band in the bottom (left) half of the gradients while the normal density strands ba.id in the top (right) half of each gradient. The normal density strands Include all of the DNA strands present in the cells prior to the transfer to labelling medium including both the template strands of the BrdUrd-containing strands and those strands not invoTved 1n DNA replication during the 6 hour labeTUng period. We have previously (12) tested the specificity of labelling of methyl-groups of cytosines with [me-Hjnethionine under those conditions using the DNA hydrolysis and base chroma tography procedure of Sano and Sager (16) .
In control cells, most ONA methyl atlon occurs in the newly synthesized strands containing BrdUrd but a small proportion (less than 10%) of methylation takes place in the DNA strands of normal density ( Figure 1A ) which were present in the cells before they were transferred to the labelling medium. This picture 1s not significantly altered 1f cells are incubated 1n this medium containing BrdUrd for 1 or 2 hours before [me-^H]methionine is added (12) .
This [me-•*H]methionine labelling of normal density strands in control cells ( Figure 1A ) cannot be due to DNA repair synthesis.
To demonstrate any repair-type synthesis in these cells requires labelling with two [^H]deoxynudeosides in the presence of BrdUrd followed by multiple bandings in isopycnic gradients (Charts 2 8 4 of reference 17). The amount of ^H observed in normal density strands after labelling with [me-Hjnethionine ( Figure 1A ) 1s at least three orders of magnitude too high for it to be due to repair-type synthesis. As can be seen in Figure 1 , 5-azaC has a major inhibitory action on non-delayed DNA methylation with a lesser degree of inhibition of delayed DNA methylatlon. The quantitative estimates of the effects of 5-azaC on delayed and non-delayed DNA methylation, and on the rate of DNA synthesis are presented in Figure 2 . The relative amounts of non-delayed methylation were calculated from the H/* These data are calculated from the gradients in Figure 1 as described 1n the Results section. The results are all expressed relative to the levels observed 1n the control ( Figure 1A) . density strands. The relative rates of ONA synthesis were calculated by two different methods. If the inhibition of replication was not severe, the rate of DNA synthesis was calculated from the ratio of the sums of the A 2 In all cases, methylation and replication are expressed relative to the ratios observed in the control cell DNA. The letters on the horizontal axis correspond to the lettering of the samples in Figure 3 . and correspond to the no drug control (A), cells treated with lmM homocysteine plus 0 up to lmM tubericidin (B through to E), and with lmM tubericidin alone differential effect was obtained at 1 ^iM 5-azaC where there was some 9 times more inhibition of non-delayed than delayed methylation.
A quite different picture of Inhibition of methylation was obtained using tubericidin (7-deaza-adenonine) plus homocysteine (18) (Figure 3 In experiments looking at the effects of Inhibitors of DNA methylation on gene activity, ethionine has been shown to induce Friend erythroleukemic cells to differentiate (4). 5-azaC has been very successfully applied in this role as an inducer of differentiation (3,6), as well as in the reactivation of inactive X-chromosomes (5). However, the interpretation of experiments using 5-azaC are clouded by the "chromosome shattering" effects of this drug (22) as well as its high toxicity (23) . Hence our Interest in other methylation inhibitors. It would be useful to have other drugs which could readily change the level of methylation in the DNA of cells without the extreme chromosome damage Induced by 5-azaC. While it is possible that the incorporation of 5-azaC Into the cellular DNA is the direct cause of this chromosome damage, it is also possible that it is a direct consequence of the reduced level of DNA methylation. However this seems unlikely since not all potentially methylated sequences are so modified in any mammalian cell and also because of the high degree of variability in the levels of DNA methylation between mammalian species (1,2) .
Hence for the experimental alteration of DNA methylation levels, we would suggest that, of the Inhibitors tested here, MTA seems to be potentially the most useful for this type of experiment with cultured mammalian cells.
As to the relevance of this data to the mode of action of these inhibitors and to the number of DNA methylases 1n these cells, the data with 5-azaC is open to a number of alternative explanations.
5-azaC has its predominant inhibitory effect on non-delayed methylation, but also inhibits to a lesser extent the delayed class of methylation reactions. Firstly this could be due to delayed and non-delayed methylation occurring in different cells (1n different parts of the cell cycle) which show differential (cell cycle stage specific) uptake of 5-azaC.
However, using synchronized cell populations, we have shown that in the latter part of S-phase, delayed and non-delayed methylation are occurring concurrently (manuscript in preparation).
Hence this explanation is most unlikely. Secondly, the differential inhibition of the two classes of DNA methylation could be due to the newly synthesized DNA containing 5-azaC and the pre-existant strands (synthesized before the labelling and drug treatment period) being free of incorporated 5-azaC (3, 24) . This is the most likely explanation of the major part of the differential effect. However, by this model there should be no inhibition of delayed methylation since these DNA strands are free from SazaC. The explanation for this 1s relevant to the question whether there is only one DNA methylase performing both delayed and non-delayed methylation reaction, or whether there are (at least) two different methylases performing the two classes of methylation.
If there were only a single DNA methylase, inhibition of primarily the non-delayed methylation with a lesser Inhibition of delayed methylation might be through the 5-azaC in the newly synthesized DNA strands irreversibly inactivating the ONA methylase molecules in the vicinity of the replication forks (24, 25) . (5-azaC inhibition of RNA methylation has also been reported to be via irreversible Inactivation of the enzyme (26)). Thus inhibition of delayed methylation might occur due to depletion of DNA methylase molecules <n the cell as a whole (24, 25) . On the other hand, if there were more than one type of DNA methylase 1n the cell performing the two different classes of DNA methylation, this would require some soluble factor to be produced in 5-azaC treated cells to produce the inhibition of the methylase acting on the DNA sequences in which methylation was delayed after strand synthesis. Hence the data with 5-azaC viewed in isolation cannot resolve the question as to whether there is one or more than one DNA methylase in these cells.
However, taken in conjunction with the data obtained with tuberiddin plus homocysteine, this question can be answered. In this case, the active inhibitor of methylation reactions 1s probably the 7-deaza-analogue of Sadenosyl-homocysteine (18) formed intracellularly from 7-deaza-adenosine (tuberiddin) with homocysteine by the enzyme S-adenosyl-L-homocyste1ne hydrolase (E.C. 3.3.1.1).
The S-tuber1cidinyl -homocysteine so formed which has been shown to be an active Inhibitor of methylation reactions using Sadenosyl methionine as a methyl-group donor (18) produces a significantly greater Inhibitory effect on the delayed class of DNA methylation reactions. This differential inhibitory effect 1s most likely explained by at least two different DNA methylases in these cells, only one of which is sensitive to inhibition by S-tuberic1dinyl-homocysteine. This would also imply that 5-azaC treatment must result In some soluble Inhibitory factor being produced in these cells which blocks delayed DNA methylation and that inhibition of DNA methylation by 5-azaC is not just due to substrate modification by 5-azaC incorporation into DNA.
If this is correct and there are different DNA methylases which perform the delayed and non-delayed classes of DNA methylation reactions, this implies that either the actual nucleotide sequences methylated by the different enzymes are different or that it is not the actual DNA sequence but some secondary factor such as chromatin structure and/or the localized secondary structure of the DNA duplex which determines which enzyme methylates that sequence. In the first case, this would be consistent with the DNA sequences showing delayed methylation having some important specialised function 1n the cell (such as control of Initiation of DNA replication as suggested by Taylor (13) , for Instance). Alternatively, the partial loss of methylation in vivo at specific sites in or near activated genes (7, 8, 9, 10) might be due to those sequences having acquired the property of delayed methylation (12) and that perhaps 1n any given cell cycle a very small proportion of the sites are not symmetrically methylated before that DNA sequence acts as a template 1n the next S-phase.
This would be consistent with the partial and also variable nature of the loss of methylation near activated DNA sequences (7,8,9,1(1) .
The activation of a gene resulting 1n localized changes in chromatin structure as well as changes 1n structure of the DNA itself (by RNA polymerase transcribing messenger RNA, for Instance) could be the direct cause of these DNA sequences exhibiting a delay 1n DNA methylation. This possibility and the possibility that the actual DNA sequences showing the delayed and non-delayed types of methylation are different are both currently under investigation.
